medicrea
-
Spine
MEDICREA’s K-JAWS(R) Obtains FDA Approval for Its Marketing in the United States
LYON, France--(BUSINESS WIRE)--August 01, 2014-- Regulatory News: The MEDICREA Group: (Paris:ALMED) (FR0004178572-ALMED), which specializes in the development of innovative surgical…
Read More » -
FRENCH FIRM PRE-CONTOURS SPINAL RODS
Biloine W. Young • Wed, April 23rd, 2014 Print this article The Medicrea Group, a Lyon, France orthopedic implant company,…
Read More » -
Medicrea Announces European Launch of UNiD, the World’s First Patient-Specific Spinal Rod
LYON, France–(BUSINESS WIRE)–The MEDICREA group (Paris:ALMED) (Alternext Paris: FR0004178572-ALMED), a company that specializes in the development of innovative surgical technologies for the treatment…
Read More » -
MEDICREA: 2010 Annual Sales
LYON, France–(BUSINESS WIRE)–The MEDICREA Group (listed on Alternext by NYSE Euronext Paris) (Paris:ALMED), a specialist in the development of innovative…
Read More » -
MEDICREA Group: Strong Sales Growth in the First Half
LYON, France–(BUSINESS WIRE)–The MEDICREA Group (Paris:ALMED)(listed on Alternext by NYSE Euronext Paris), a specialist in the design, manufacture and sale…
Read More » -
MEDICREA Pursuing a Solid Increase in Sales
LYON, France–(BUSINESS WIRE)–The MEDICRA Group (Paris:ALMED), listed on Alternext by NYSE – Euronext Paris, a specialist in the design, manufacture…
Read More » -
MEDICREA Group: Record Business Activity in 2009
LYON, France–(BUSINESS WIRE)–The MEDICRA Group (Paris:ALMED), listed on Alternext by NYSE – Euronext Paris, a specialist in the design, manufacture…
Read More » -
MEDICREA : Excellent Business Activity in Third Quarter 2009
LYON, France–(BUSINESS WIRE)–The MEDICREA Group (Paris:ALMED), listed on Alternext by NYSE – Euronext Paris, a specialist in the design, manufacture…
Read More »